FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

17 results

akeega
(NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE)
Janssen Biotech, Inc.
Usage: AKEEGA, in combination with prednisone, is indicated for adult patients with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). Treatment selection should be based on an FDA-approved test for AKEEGA.
darzalex
(Daratumumab)
Janssen Biotech, Inc.
Usage: DARZALEX is indicated for adult patients with multiple myeloma, used in various combinations with other therapies for newly diagnosed patients ineligible for stem cell transplant, relapsed or refractory cases after prior treatments, and as monotherapy for patients with extensive treatment history or double-refractory status.
darzalex faspro - daratumumab and hyaluronidase - fihj
(Daratumumab And Hyaluronidase-Fihj (Human Recombinant))
Janssen Biotech, Inc.
imaavy - nipocalimab injection, solution, concentrate
(Nipocalimab)
Janssen Biotech, Inc.
infliximab - infliximab injection, powder, lyophilized, for solution
(Infliximab)
Janssen Biotech, Inc.
lazcluze
(lazertinib)
Janssen Biotech, Inc.
Usage: LAZCLUZE, in combination with amivantamab, is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations (exon 19 deletions or exon 21 L858R) as determined by an FDA-approved test.
remicade
(INFLIXIMAB)
Janssen Biotech, Inc.
Usage: REMICADE is indicated for treating moderate to severe Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults. It is also approved for pediatric Crohn's and ulcerative colitis. The drug helps induce and maintain remission and reduce symptoms.
rybrevant
(Amivantamab)
Janssen Biotech, Inc.
Usage: RYBREVANT is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR mutations. It is used as a first-line therapy or for previously treated patients, in combination with other agents or as a single agent, depending on mutation type.
rybrevant faspro
(Amivantamab And Hyaluronidase-Lpuj (Human Recombinant))
Janssen Biotech, Inc.
simponi
(golimumab)
Janssen Biotech, Inc.
Usage: SIMPONI is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis (with methotrexate), active psoriatic arthritis, active ankylosing spondylitis, and moderately to severely active ulcerative colitis in patients who are corticosteroid-dependent or intolerant to other treatments.

Janssen Biotech, Inc. drugs

akeega

darzalex

darzalex faspro - daratumumab and hyaluronidase - fihj

imaavy - nipocalimab injection, solution, concentrate

infliximab - infliximab injection, powder, lyophilized, for solution

lazcluze

remicade

rybrevant

rybrevant faspro

simponi